Alpha Diagnostic International, Inc. Anti-mouse Vasoactive intestinal peptide receptor (VIPR1/VPAC1) IgG #1, aff pure VIPR11-A

Anti-mouse Vasoactive intestinal peptide receptor (VIPR1/VPAC1) IgG #1, aff pure General Information VIPR1 is a 457aa (chr. 3p22) glycosylated receptor in human (459aa in rat, 459aa in mouse) has a signal peptide sequence with several transmembrane domains. The VIP receptor 1 is also termed as type II PACAP receptor, RCD1. It is predominantly expressed i SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Mouse SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Affinity purified IgG SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 17-aa peptide from Mouse VIPR (1); Designation (VIPR11-P, control peptide) epitope location ~ N-terminus SpCrossreactivity The mouse VIPR11-P control peptide is 100% conserved in rat, and 90% in human. No significant homology is detected with other species. Antibody cross-reactivity in various species has not been studied For research use only, not for diagnostic or therapeutic use.